Type I interferon signature: a quantitative standardized method for clinical application

Area of Science:

• Immunology
• Molecular Biology
• Clinical Diagnostics

Background:

• Type I Interferon (IFN) signature analysis is crucial for classifying inflammatory diseases and guiding personalized therapies.
• Current methods lack standardization, hindering inter-center data comparison and clinical application.
• Challenges exist in differentiating IFN-related inflammation from other cytokine-mediated conditions.

Purpose of the Study:

• To develop and validate a standardized method for Type I IFN signature analysis.
• To address the limitations of current methods by introducing a synthetic control.
• To improve the reproducibility and comparability of IFN signature measurements across different laboratories and time points.

Main Methods:

• Development and validation of a standardized assay incorporating a synthetic control.
• Assessment of inter-assay and inter-laboratory variability through repeated analyses.
• Validation in a cohort of 39 patients with diverse inflammatory disorders, including monogenic interferonopathies, systemic lupus erythematosus, juvenile dermatomyositis, periodic fevers, and juvenile idiopathic arthritis.

Main Results:

• The proposed method demonstrated high reproducibility across different centers.
• The assay effectively discriminated between IFN-related and non-IFN-related inflammatory conditions.
• The synthetic control significantly minimized inter-assay and inter-laboratory variability.

Conclusions:

• The standardized method provides a reliable tool for Type I IFN signature analysis in clinical practice.
• This approach facilitates data sharing among research centers, advancing the understanding of IFN-related inflammation.
• Improved diagnostic capabilities can lead to enhanced patient care for individuals with IFN-related disorders.